ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,227Medicare Part D Prescriptions Filled, Including Refills

Rank: 304 out of 1111

$577K Total Retail Price of All Prescriptions

Rank: 164 out of 1111

395 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 395 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

1% of this provider’s 6,311 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$80 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
PRAVASTATIN SODIUM 361 325 1 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 276 253 2 23
AMLODIPINE BESYLATE 261 247 3 7
ENALAPRIL-HYDROCHLOROTHIAZIDE 188 181 4 284
CARVEDILOL 187 174 5 21
LEVOTHYROXINE SODIUM 170 140 6 3
GEMFIBROZIL 162 146 7 92
NIASPAN 154 148 8 164
METFORMIN HCL 149 133 9 8
ZETIA 140 124 10 109
FUROSEMIDE 137 115 11 6
ATORVASTATIN CALCIUM 134 129 12 15
POTASSIUM CHLORIDE 126 122 13 9
HYDROCHLOROTHIAZIDE 122 113 14 11
OMEPRAZOLE 119 105 15 4
WARFARIN SODIUM 113 95 16 19
LISINOPRIL 104 96 17 2
DIOVAN 102 97 18 51
METOPROLOL SUCCINATE 101 81 19 20
DIOVAN HCT 97 87 20 94
CRESTOR 94 90 21 33
GLIMEPIRIDE 90 75 22 61
PAROXETINE HCL 88 70 23 55
ADVAIR DISKUS 84 77 24 43
METOPROLOL TARTRATE 82 81 25 12
TRICOR 79 78 26 157
DIGOXIN 78 58 27 47
GABAPENTIN 71 43 28 10
CLOPIDOGREL 69 66 29 30
ENALAPRIL MALEATE 65 56 30 56
RANITIDINE HCL 64 56 31 29
NIFEDIPINE ER 62 46 32 185
AMLODIPINE BESYLATE-BENAZEPRIL 57 47 33 67
RAMIPRIL 56 47 34 168
FLUTICASONE PROPIONATE 56 54 34 27
LOVASTATIN 52 46 36 41
KLOR-CON M20 51 51 37 79
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 29, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.